Literature DB >> 7002066

Antirheumatic activity of fenclofenac.

H Berry, A W Ford-Hutchinson, A V Camp, D Heywood, M G Molloy, D W James, E B Hamilton.   

Abstract

This study has set out to establish whether fenclofenac has an antirheumatic effect in addition to its anti-inflammatory and analgesic activity. The results show that during the course of a 6-month study the drug improved clinical parameters, including the articular index, early morning stiffness, ring sizes, and grip strength, and produced changes in laboratory measurements such as the levels of C-reactive protein, IgG, and rheumatoid factor.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002066      PMCID: PMC1000588          DOI: 10.1136/ard.39.5.473

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  3 in total

1.  Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis.

Authors:  H Berry; L Fernandes; A W Ford-Hutchinson; S J Evans; E B Hamilton
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

2.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

3.  Anti-inflammatory and related properties of 2-(2,4-dichlorophenoxy)phenylacetic acid (fenclofenac).

Authors:  D C Atkinson; E C Leach
Journal:  Agents Actions       Date:  1976-09
  3 in total
  3 in total

1.  Pharmacokinetics of fenclofenac in children with juvenile rheumatoid arthritis.

Authors:  A L Mäkelä; M Scheinin; E Iisalo; J S Salonen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 2.  Non-steroidal anti-inflammatory drugs. Current status and rational therapeutic use.

Authors:  F D Hart; E C Huskisson
Journal:  Drugs       Date:  1984-03       Impact factor: 9.546

3.  Drug trials in rheumatoid arthritis.

Authors:  H Berry
Journal:  J R Soc Med       Date:  1980-12       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.